Ireland
--:--IST
Recruiting Not applicable

Mother-infant Bonding in the Brain: a Mindfulness-based Intervention

NCT05830266 · tracked via the Priya Life Science Netherlands tracker
Phase
Not applicable
Started
2023-07-01
Last updated
2026-10-15

Condition(s) studied

Postpartum DepressionPostpartum AnxietyParental Stress

Investigational drug(s) / intervention(s)

"Mindful with your Baby" group-based therapist-guided intervention"Mindful with your baby" self-guided online intervention

"Mindful with your Baby" group-based therapist-guided intervention: This 8-sessions long intervention is one of very few interventions that actively includes the baby in the therapy sessions. The intervention includes the following sessions: "Becoming aware of the autopilot", "Practice to really look at your baby", "Getting back in touch with yourself", "Responding sensitively to your baby", "Taking care of yourself in the difficult moments", "Distance and proximity: it's both part of it", "Dealing with expectations of yourself and the environment" and "Mindful parenting: trial and error". The intervention is a group-based therapist-guided intervention via a video-conferencing tool (e.g., Zoom).

"Mindful with your baby" self-guided online intervention: This 8-sessions long intervention includes the following sessions: "Autopilot", "Fresh view", "At home in your body", "Responsive versus reactive parenting", "Kindness to yourself", "Distance and proximity", "Boundaries and taking care of yourself" and "Mindful parenting - day by day". The intervention is an individual self-guided online intervention.

Study summary

The study investigates the effectiveness of the mindfulness-based intervention "Mindful with your Baby" in women with babies between 5-9 months postpartum who experience heightened levels of postpartum depression, anxiety and/or parental stress. The intervention "Mindful with your Baby" is one of the very few interventions for maternal postnatal mental health issues that takes the bond between mother and infant into account. It is hypothesized that the "Mindful with your Baby" intervention will reduce levels of postpartum depression, anxiety and parental stress, and improve mother-infant behavioral interaction and increase neural synchrony between mother and infant brains.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Pregnant women (18+y). * First antenatal visit \< 12 weeks. * Score above cut off on the Edinburgh Postnatal Depression Scale (EPDS), the anxiety subscale of the Symptom Checklist (SCL-90) and/or the Parental Stress Questionnaire (PSQ) at 8-10 weeks postpartum. * Dutch-speaking or understanding Dutch. Exclusion Criteria: * Gemelli pregnancy (or higher order pregnancy). * Known endocrine disorder before pregnancy (diabetes-I, Rheumatoid arthritis). * Severe psychiatric disease (schizophrenia, borderline or bipolar disorder). * HIV. * Drug or alcohol addiction problems. * Any other disease resulting in treatment with drugs that are potentially adverse for the fetus and need careful follow-up during pregnancy. * No access to the internet.

Primary outcome measure(s)

  • Change from baseline postpartum depressive symptoms — before the intervention (baseline, week 0), halfway through the intervention (week 4), post-intervention (week 8) and after 10-weeks follow-up (week 18)
    Assessed with the 10-item Edinburgh Postnatal Depression Scale (EPDS). The EPDS is the most widely used self-rating scale to assess depressive symptoms in the perinatal period. The EPDS total score ranges from 0 to 30, with higher scores indicating more depressive symptoms. The questionnaire has been validated in Dutch postpartum women.
  • Change from baseline postpartum anxiety symptoms — before the intervention (baseline, week 0), halfway through the intervention (week 4), post-intervention (week 8) and after 10-weeks follow-up (week 18)
    Assessed with the 10-item anxiety subscale of the Symptom Checklist (SCL-90). The total scores range from 10 to 50 and higher scores reflect more anxiety symptoms. The questionnaire has showed good reliability and validity in non-pregnant samples.
  • Change from baseline parental stress — before the intervention (baseline, week 0), halfway through the intervention (week 4), post-intervention (week 8) and after 10-weeks follow-up (week 18)
    Assessed with the Parental Stress Questionnaire (PSQ, in Dutch: Opvoedingsbelastingvragenlijst), which is based on the Parenting Stress Index. This study uses only the first three subscales related to parenting: parent-child relationship problems, parenting problems and parental role restriction. Total scores range from 19 to 76 with higher scores indicating more parental stress. In order to interpret the level of parental stress experienced, subscale scores are converted into T-scores conform the norms of the child's age (e.g., 0 to 3 years). The questionnaire and subscales have showed good reliability and validity.
  • Change from baseline mother-infant bonding — Before the intervention (baseline, week 0) and post-intervention (week 8)
    Assessed with video coding
  • Change from baseline neural synchrony between mother and infant (EEG outcome 1) — Before the intervention (baseline, week 0) and post-intervention (week 8)
    Assessed with dual-EEG, with the Phase Locking Value (PLV) in the alpha band frequency (6-9 Hz) during the free play task. We expect that neural synchrony between mother and infant will increase (more) in the intervention group.
  • Change from baseline neural synchrony between mother and infant (EEG outcome 2) — Before the intervention (baseline, week 0) and post-intervention (week 8)
    Assessed with dual-EEG, with the Phase Locking Value (PLV) in the alpha band frequency (6-9 Hz) during the still face paradigm. We expect that neural synchrony between mother and infant will increase (more) in the intervention group.

Trial sites (1)

FacilityCityRegionStatus
Tilburg University Tilburg North Brabant Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05830266 on ClinicalTrials.gov ↗ ← All trials in the Netherlands